Related Experiment Video
Updated: Jun 29, 2025
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
Insights
Atopic dermatitis (AD) is a common skin condition in children. Primary care providers play a key role in recognizing AD and managing its treatment, which includes skin care, topical medications, and monitoring for complications.
Area of Science:
- Pediatric dermatology
- Clinical medicine
Background:
- Atopic dermatitis (AD) is highly prevalent in children.
- Primary care providers (PCPs) are often the first point of contact for pediatric AD.
- Recognizing AD involves identifying key clinical features like itch and characteristic eruptions.
Purpose of the Study:
- To outline the essential knowledge for PCPs in managing pediatric atopic dermatitis.
- To emphasize the importance of early recognition and appropriate treatment of AD.
- To highlight the impact of AD on quality of life and the need for comprehensive management.
Main Methods:
- Clinical recognition of atopic dermatitis based on established features.
- Implementation of a multi-modal treatment approach including skin care and pharmacotherapy.
- Monitoring for medication side effects and AD complications, particularly secondary infections.
Main Results:
- Effective management of pediatric AD relies on consistent dry skin care and emollient application.
- Topical corticosteroids and nonsteroidal therapies are standard treatments.
- Systemic therapies and novel agents may be necessary for severe cases.
Conclusions:
- PCPs require a thorough understanding of AD pathogenesis, treatment, and complications.
- Untreated or undertreated AD significantly affects children's and caregivers' quality of life.
- Prompt and accurate management by PCPs is crucial for optimal outcomes in pediatric AD.
Abstract:
Atopic dermatitis (AD) is extremely common in the pediatric population, and most children with AD will first present to their primary care provider (PCP). The PCP can recognize AD by its clinical features, including itch, a chronic relapsing course, and the characteristic eruption. The cornerstone of AD therapy is dry skin care, typically a short daily bath/shower followed by an emollient applied to all skin. Most children with AD will also require topical medications, such as topical corticosteroids and/or topical nonsteroidal therapies. For children with more severe disease, systemic agents, including several novel therapies, may be required. In managing AD, the clinician must monitor for side effects of medications as well as complications of the AD itself, the most common of which is secondary infection. An understanding of the pathogenesis, treatments, and complications of AD is essential for the PCP, as untreated (or undertreated) AD has a significant impact on the quality of life of affected children and their caregivers. [.
Related Concept Videos
01:23Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
01:26Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:29Asthma-I: Introduction
02:06Allergic Reactions
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation